Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Number of Sell Recommendations

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

162.91
Price
–
Fair Value
–
Upside
140.68 - 169.99
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Number of Sell Recommendations:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240
Performance Summary
  • Johnson & Johnson's number of sell recommendations is 0

How does J&J's Number of Sell Recommendations benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

J&J Number of Sell Recommendations Benchmarks
NameTickerNumber of Sell Recommendations
Johnson & JohnsonNYSE:JNJ0
HealthcareSECTOR:HLTH.US0
Merck & Company IncNYSE:MRK0
Eli Lilly and CompanyNYSE:LLY0
Talphera IncNASDAQGM:TLPH0
Nutriband IncNASDAQCM:NTRB0
Vyne Therapeutics IncNASDAQCM:VYNE0
NovaBay Pharmaceuticals IncNYSEAM:NBY0
Viatris IncNASDAQGS:VTRS0
ANI Pharmaceuticals IncNASDAQGM:ANIP0
Bristol-Myers Squibb CompanyNYSE:BMY1
Novartis AG ADRNYSE:NVS2

Metric Usage: Number of Sell Recommendations

Hide this widget
analyst_sell_rec_count
Slug
number
Datatype
text
Format
current
Default Period
D
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Number of Sell Recommendations in the predictions category include:

  • Analyst Price Target Median - The median analyst price target for a stock. Price targets represent what analysts believe a stock will be worth within the next 12 to 18 months.
  • Predicted EV Growth Exit Rate (FY+10) - Our estimate of the fair value EV Growth Exit Rate (FY+10) for a company.
  • Fair Value Confidence - The percentage increase (if positive) or decrease (if negative) that our models estimate over the current stock price. Fair value serves as a tool for investors and analysts to evaluate whether an asset is overvalued or undervalued in relation to its intrinsic worth.
  • Number of No Opinion Recommendations - The number of analysts publishing a No Opinion recommendation for the stock.
View Full List

Search for metric or datapoint

Number of Sell Recommendations

The number of analysts publishing a Sell recommendation for the stock.

Definition of Number of Sell Recommendations

Hide this widget
The number of analysts publishing a Sell recommendation for the stock.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
001105001,0001,5002,000

The chart above depicts the distribution of number of sell recommendations for companies operating in the Healthcare sector in the Developed economic region. Over 2,220 companies were considered in this analysis, and 2,202 had meaningful values. The average number of sell recommendations of companies in the sector is 0 with a standard deviation of 0.

Johnson & Johnson's Number of Sell Recommendations of 0 ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:

Number of Sell Recommendations In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,227
Included Constituents2,202
Min0
Max1
Median0
Mean0
Standard Deviation0

You can find companies with similar number of sell recommendations using this stock screener.

All rights reserved. Terms Of Use